2025 has been a dynamic year for pharma. Breakthroughs in AI-driven drug discovery and precision medicine have reshaped how treatments are developed and delivered, and major drug launches have further highlighted the industries’ efforts to serve unmet needs. This was also a year of significant regulatory shifts, which brought increased scrutiny on drug pricing, consumer advertising, evidence needs, and vaccine policy changes, among other issues. Despite the breakthroughs, this year has been characterized by widespread uncertainty about the future.
Read the full article: Pharmaceutical Commercialization: A 2026 Outlook //
Source: https://www.pharmexec.com/view/pharmaceutical-commercialization-a-2026-outlook-personalization-and-precision-will-define-a-new-year-in-pharma